Latest news with #HepatitisB.
India Today
27-05-2025
- Health
- India Today
Preventing Hepatitis B in newborns: Ministry of Health urges timely vaccination
The Ministry of Health and Family Welfare (MoHFW), Government of India, emphasized the urgent need to prevent mother-to-child transmission of Hepatitis B. The ministry is advocating for universal screening of pregnant women and ensuring that all newborns receive the birth dose of the Hepatitis B vaccine within 24 hours of B, a serious liver infection caused by the Hepatitis B virus (HBV), is commonly transmitted from mother to child during childbirth. Early intervention through testing and vaccination can significantly reduce the risk of transmission, contributing to better public health GUIDLINESFor pregnant women Mandatory testing: All pregnant women should be tested for Hepatitis B at healthcare delivery: Women testing positive should deliver at a healthcare facility to ensure proper medical newbornsTimely vaccination: Every newborn should receive a birth dose of the Hepatitis B vaccine, preferably within 24 protection: If the mother is Hepatitis B positive, the baby should also receive Hepatitis B Immune Globulin (HBIG) along with the SERVICES AVAILABLEThe ministry assures that testing, vaccines, and HBIG are available free of cost at all designated government healthcare facilities. Citizens can also contact the national toll-free helpline 1800-11-6666 for more initiative is part of MoHFW's broader #HealthForAll campaign, reinforcing the government's commitment to accessible and equitable healthcare for every Ministry of Health and Family Welfare (MoHFW), Government of India, is the apex body responsible for health policy, awareness, and services across the country. The ministry leads national programs focused on public health, immunisation, and disease prevention.
Los Angeles Times
03-04-2025
- Health
- Los Angeles Times
Understanding Hepatitis C: Symptoms, Causes, and Treatment Options
Hepatitis C is a serious condition that can greatly affect your liver and overall health. The culprit is a virus called hepatitis C virus (HCV), which typically gets into a person's system through direct contact with infected blood. Once inside the body, it hones in on liver cells and might stay hidden for years. Some folks experience obvious symptoms pretty quickly, while others don't notice anything until the virus has done some damage. Unfortunately, when the infection goes unnoticed, it can quietly cause long-term harm to the liver [1]. Table of Contents Hepatitis C continues to pose a big global challenge, even compared to Hepatitis E and Hepatitis B. According to estimates, somewhere between 57 and 71.1 million people around the world live with chronic hepatitis C [1, 3]. Each year, roughly 300,000 individuals die from serious complications like advanced liver disease and liver cancer. Experts often label HCV as the top cause of chronic liver disease internationally. That's why it's so essential to raise awareness and support prevention strategies [10]. The virus mostly spreads through blood contact [8]. Years ago, before tests became strict, blood transfusions were a leading cause of infection. But with better screening today, the risk of infection from donated blood is way down. Another issue is the re-use of needles and syringes in healthcare settings or among people who use drugs, as that can directly pass HCV from one person to another. People who inject drugs are especially at risk if they share needles or other equipment [3]. Understanding these pathways helps experts tackle this ongoing public health concern. Many people with hepatitis C don't have any noticeable symptoms early on [2]. Acute hepatitis C, which is the initial phase, can sneak in without showing any big red flags. On average, it takes about seven weeks for signs to appear, and only around one-third of people see any real problems in the acute stage, such as tiredness, joint aches, or a slight fever. If the virus isn't cleared, the infection might become chronic [9]. About 85% of acute cases progress to chronic hepatitis C if not treated [7]. Over years or decades, this prolonged infection can damage the liver to the point of triggering problems like jaundice (yellowish skin and eyes), fluid buildup in the belly, or weakness. HCV is basically a thread of RNA, which is genetic material, that specifically attacks liver cells. One of its sneakier moves is dodging the immune system; in most infected individuals, the immune system never fully clears it [4]. What's interesting is that HCV usually doesn't kill liver cells directly. Instead, your immune system's response does much of the damage. Over time, this ongoing battle between the virus and the immune defenses leads to scars in the liver, which can bring on more severe issues down the line [10]. If hepatitis C isn't controlled, it tends to wear down the liver bit by bit. A major concern is cirrhosis, which is when the liver develops a lot of scar tissue, making it tougher for the liver to handle its usual tasks. Cirrhosis can show up after 20 or 30 years of chronic infection, but it can happen sooner, too, depending on other factors. In worse cases, cirrhosis progresses to decompensated liver disease, meaning the liver can't keep up with what your body needs. Another risk is hepatocellular carcinoma (HCC), a dangerous liver cancer that can arise in people with long-term HCV [1, 6]. Certain things can make hepatitis C more severe or speed up its complications. People who get infected later in life sometimes experience liver damage at a faster rate than those infected at younger ages. Gender and race may also influence how quickly the disease develops, though researchers are still finding out exactly why. Drinking alcohol is another major factor—it puts added stress on the liver, possibly pushing liver damage along faster [4]. Knowing these risks helps doctors and patients pinpoint strategies to prevent further harm. The upside is that awareness, testing, and effective therapies have come a long way lately. Modern antiviral medications can do a great job of clearing the virus and heading off more serious damage [5]. Getting diagnosed early is key, because it gives people a chance to start treatment before cirrhosis or other advanced problems set in. Prevention is also super important. Simple but crucial measures, like sterilizing medical tools, improving safe injection practices, and rigorously screening blood donations, drastically reduce transmission. Around the globe, ongoing medical research aims to curb or even completely eliminate hepatitis C as a health threat in the future. Hepatitis C is a wide-reaching liver infection that can quietly linger without causing immediate trouble. If nobody catches it early on, the infection can stick around for years, eventually leading to serious complications like cirrhosis and liver cancer. Because HCV mainly travels through blood contact, reducing exposure to infected blood and staying informed about how the virus spreads can make a big difference. Recognizing the symptoms, understanding your own risk factors, and getting tested as needed are all vital steps. Medical advances give hope that, through early detection and better treatments, we can slash new cases, successfully cure existing infections, and lessen the worldwide toll of hepatitis C. [1] Martinello, M., Solomon, S. S., Terrault, N. A., & Dore, G. J. (2023). Hepatitis C. Lancet (London, England), 402(10407), 1085–1096. [2] Simmonds P. (2013). The origin of hepatitis C virus. Current topics in microbiology and immunology, 369, 1–15. [3] Spearman, C. W., Dusheiko, G. M., Hellard, M., & Sonderup, M. (2019). Hepatitis C. Lancet (London, England), 394(10207), 1451–1466. [4] Kohla, M., & Bonacini, M. (2006). Pathogenesis of hepatitis C virus infection. Minerva gastroenterologica e dietologica, 52(2), 107–123. [5] Manns, M. P., & Maasoumy, B. (2022). Breakthroughs in hepatitis C research: from discovery to cure. Nature reviews. Gastroenterology & hepatology, 19(8), 533–550. [6] Puchades Renau, L., & Berenguer, M. (2018). Introduction to hepatitis C virus infection: Overview and history of hepatitis C virus therapies. Hemodialysis international. International Symposium on Home Hemodialysis, 22 Suppl 1, S8–S21. [7] Hoofnagle J. H. (1997). Hepatitis C: the clinical spectrum of disease. Hepatology (Baltimore, Md.), 26(3 Suppl 1), 15S–20S. [8] Dustin, L. B., Bartolini, B., Capobianchi, M. R., & Pistello, M. (2016). Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 22(10), 826–832. [9] Delahooke T. E. (2004). Hepatitis C: What is the nature of the problem?. Journal of viral hepatitis, 11 Suppl 1, 5–11. [10] Boyer, N., & Marcellin, P. (2000). Pathogenesis, diagnosis and management of hepatitis C. Journal of hepatology, 32(1 Suppl), 98–112.
